Our innovative robots offer surgeons superior surgical outputs. Skywalker™ Orthopedic surgery navigation and positioning system is a one-of-a-kind surgical robotic product for Total Knee Arthroplasty (TKA) helping orthopedic surgeons resolve issues faced during traditional surgery and achieve higher accuracy and efficiency. Ultimately, Skywalker reduces trauma and bleeding for patients during surgery, and enables a faster recovery process post operation. In addition, our Toumai™ Endoscopic Surgery Robot successfully completed its First-In-Man (FIM) trial for Robot Assisted Laparoscopic Radical Prostatectomy (RALRP) on November 1st, 2019.
Skywalker™ is a robotics system independently developed by MicroPort to carry out total knee arthroplasty (TKA), completed First In Man Clinical Trial (FIM) at Ninth People’s Hospital Shanghai on June 30th 2020. Director Li Huiwu and his team successfully completed the operation on a female patient to restore her lower limb function.
Skywalker Orthopedic surgery navigation and positioning system is a one of a kind surgical robotic product for TKA. Compared with traditional joint replacement surgery, robot assisted joint replacement surgery can help orthopedic surgeons resolve issues faced during traditional surgery and achieve higher accuracy and efficiency.
Skywalker features a preoperative planning system, which could generate a personalized surgical scheme for patients based on the data collected from 3D CT scanning. It also features a highly dexterous lightweight manipulator and a semi-auto operation mode that allows for smooth completion of the osteotomy process, which improves the operation efficiency, surgical accuracy, as well as reducing the space needed to carry out surgery. Ultimately Skywalker reduces trauma and bleeding for patients during surgery, and enables a faster recovery process post operation.
"Skywalker’s highly precise navigation and positioning system, in combination with semi-automated osteotomy solution, offers surgeon superior surgical outcomes, that reduces trauma and bleeding to patients." Director Li Huiwu
Toumai™ Endoscopic Surgery Robot
Toumai™ Endoscopic Surgery Robot successfully completed its First-In-Man (FIM) trial for Robot Assisted Laparoscopic Radical Prostatectomy (RALRP) at Shanghai Oriental Hospital on November 1st 2019. Under the guidance of Academician Sun Yinghao, RALRP was provided to a 65 year old local patient, who was admitted to the hospital for early prostate cancer, the whole surgery lasted 1.5 hours. Post-surgery, the patient recovered with good health.
Compared with traditional laparoscopic surgery, robot assisted surgery has the advantages of providing real-time 3D vision, and precise control of the surgical arms, which allows for highly dexterous manipulation within a narrow space, thereby shortening time of the operation, reducing surgical trauma, and is more conducive to the protection of nerves and blood vessels. Post-surgery, patients' physiological functions such as urinary control and erectile ability are preserved.
“Whether it is the high-definition visual effects presented by 3D laparoscopy, or the dexterity and precision provided by the surgical arm. The Toumai™ Endoscopic Surgery Robot is able to provide performance that is on par with global leaders in the field, and is competent in fulfilling the complex and delicate demands of a radical prostatectomy surgery.” Academician Sun Yinghao.
Innovation During COVID-19
Bronchoscopy is considered an important diagnostic and therapeutic tool in the treatment of the Novel Coronavirus COVID-19, however it is also the process with the highest risk of contamination for healthcare professionals.
Patients who are infected with COVID-19, have reduced ability to cough and expectorate, which leads to the further decline of the lung’s oxygenation function. Sputum and mucus depository in critically ill patients lead to further aggravation of symptoms and treatment difficulties. Bronchoscopy assisted sputum aspiration, and lavage are important treatment methods for severely affected patients with symptom relief and assistance with recovery. In addition patients infected with COVID-19, may need to have a tracheotomy performed or undergo intubation. Bronchoscopy can be used for guiding and monitoring during this process. However, because the strong infectivity of COVID-19 and high concentration of the virus in the mucus of the lower respiratory tract, aerosol could form as the airways are opened during operations, resulting in a high risk of contamination of the medical staff.
On April 24th 2020, the MicroPort MedRobot team in collaboration with Shanghai Jiao Tong University, carried out the first-in-human robot assisted bronchoscopy treatment of COVID-19, the procedure was performed on a 55 year old patient suspected of COVID-19 infection. During the procedure, a series of bronchoscopy operations were performed, including sputum suction, alveolar lavage and lavage fluid collection were completed using a remotely controlled robot, with medical staff isolated from the operation room.
Professor Sun Jiayuan said after the operation: "No adverse reactions were observed during and after operation. With the continuous emergence of new pathogenic microorganisms, bronchoscopy for patients suspected of pulmonary infectious diseases may put the healthcare staff at risk. Robots could both reduce the number of staff required for this operation, as well as provide enhanced protection from contamination.”
Although the surgical robot was developed initially to provide bronchoscopy for patients with COVID-19, there is also important clinical value for patients infected with other highly infectious respiratory diseases such as tuberculosis. This is the first reported instance where a surgical robot was utilized to provide bronchoscopy to patients infected with COVID-19 worldwide.